In addition, andrographolide reduced hepatoma cancer cells’ growth, inhibiting vascular endothelial growth factor A expression via HIF-1α degradation [24], which also suggests that andrographolide could interfere with cell metabolism in cancer. This evidence concerns the gene HIF1A and cancer.